Therapix Biosciences Ltd ADR | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
Therapix Biosciences: Small IPO With Big League Potential
Article By: Stone Fox Capital
Wednesday, March 22, 2017 11:48 AM EDT
Therapix Bio offers investors an under the radar IPO in the hot cannabinoid market with a promising pipeline.
In this article: THXBY, TRPX, SPRCY Also: GWPH, ZYNE, OWCP, CNBX
Week In Review: Otsuka Pays $78 Million For Asian Rights To Ariad's Leukemia Drug
Article By: ChinaBio® Today
Sunday, December 28, 2014 6:01 AM EDT
Otsuka will pay $77.5 million upfront plus additional regulatory milestones. Ariad will receive a "substantial" share of net product revenues.
In this article: ARIA, CRME, CRPNF, THXBY, OTSKF

Latest Tweets for $THXBY

No tweets yet!